Video & Transcript Research : 'pharmacy practice'

Page 20 of 500
HI

Hawaii 2025 Regular Session

JHA Public Hearing - Tue Feb 25, 2025 @ 2:00 PM HST

Judiciary & Hawaiian Affairs

Transcript Highlights:
  • us to provide access beyond just the pharmacies that are physically located.
  • <00:23:31.240> is savings um the contract Pharmacy is savings um the contract Pharmacy is
  • by by Pharmacy companies and implemented by by Pharmacy companies and what<00:24:11.200> we<00
  • office practicing law in the defender office practicing law in the public<01:42:01.199> defender's
  • The Office of Information Practices opposes this bill.
Keywords: 910, house, all
Summary: The committee first heard House Bill 302, which would repeal the requirement that a provider-patient relationship for medical cannabis certification be established in person first. The Department of Health said it supported the House Draft 2 version as a way to expand patient access, and several testifiers from the medical cannabis community and dispensary industry supported the bill, especially for patients on outer islands or those unable to travel. One witness asked that earlier language removed in committee be restored to further improve access. Representative Shimizu asked whether follow-up in-person visits would still occur, and DOH responded that this varies by provider, with some continuing in-person care and others moving to telehealth for chronic conditions. The committee then took up House Bill 712, relating to the federal 340B drug pricing program and contract pharmacies. The Office of Consumer Protection and the Attorney General’s office both said they supported the bill’s purpose but wanted it clarified and possibly moved into a standalone chapter rather than chapter 481B. Supporters, including Hawaii Pacific Health and the Queen’s Health Systems, said the bill is needed to protect safety-net funding and access to discounted drugs, citing large financial benefits from 340B and losses caused by manufacturer restrictions on contract pharmacies. PhRMA opposed the bill, arguing the issue is not access to discounts but accountability and transparency in how contract pharmacies distribute benefits, and said it was willing to discuss amendments. Members asked follow-up questions about whether there was data showing misuse; PhRMA said it did not have numbers, while hospital witnesses said the program is federally audited and used appropriately in Hawaii. Finally, the committee heard House Bill 1482, HD1, which would tighten hemp and controlled-substance definitions to exclude Schedule I cannabinoids from manufactured hemp products and clarify the treatment of artificially derived cannabis. The Department of Health supported the measure, saying it adds clarity to existing prohibitions. Kūre Hawaii and other supporters said it would close loopholes involving Delta-8 and similar products. An individual testifier urged stronger language to also cover compounds such as HHC, THCA, THCP, and THCO. In response to questions about enforcement against mislabeled hemp products, DOH explained that THC percentages are relative to product weight, that some products can remain under the hemp threshold while still containing significant THC, and that hemp flower is already prohibited from direct retail sale, though enforcement can be complicated and involves both administrative and criminal authorities.
KY
Transcript Highlights:
  • <00:16:41.360> benefit insurance committee um Pharmacy benefit insurance committee um Pharmacy
  • artificially high prices at the pharmacy artificially high prices at the pharmacy counter<00:19:
  • I was able to pull just some Anthem data from our pharmacy retail pharmacy in Campbellville for 2024.
  • uh Retail Pharmacy from our uh Pharmacy uh Retail Pharmacy in<00:41:32.640> campbellville<00:
  • entertained a great deal of of Pharmacy entertained a great deal of of Pharmacy legislation<00:43
Summary: The House Standing Committee on Banking and Insurance met with a quorum and first took up Senate Bill 145, sponsored by Sen. David Givens. The bill would update retail installment contract statutes for automobile sales, allowing retailers with installment contracts shorter than 28 days to begin collections after three days instead of waiting for multiple missed payments, and it also harmonizes a related dollar amount in statute from $10 to $15. The committee asked no questions, and the bill received a favorable expression on a roll-call vote. The committee then heard Senate Bill 183 from Sen. Matt Nunn, with testimony from Chris Nolan of the American Property Casualty Insurance Association. The bill would require proxy advisers acting for the State Retirement System to act solely in the financial interest of current and future retirees and to avoid political or social considerations in shareholder voting recommendations. Supporters argued it would keep politics out of public pensions and align proxy advice with fiduciary duties; members praised the bill and noted Kentucky could be among the first states to adopt such a model. The committee approved the bill with favorable expression after a roll-call vote. The committee also reviewed administrative regulation 808 KAR 9:10 from the Department of Financial Institutions, with no vote required. It then took up House Bill 413, a PBM rebate pass-through bill, with testimony from Sarah Wood of the Diabetes Patient Advocacy Coalition. She said the bill would require 85% of negotiated drug rebates to be passed through to patients at the point of sale, lowering out-of-pocket costs, especially for high-rebate drugs such as insulin, while still allowing 15% to remain with plans. She cited examples from other states and argued the bill would benefit about 650,000 Kentuckians. Hope McClaflin of Anthem opposed the bill, saying it would reduce employers’ ability to use rebates to lower premiums, could disproportionately favor high-cost brand-name drug users, and could create significant costs for state and fully insured plans. Members asked questions about other states’ pass-through rates and the effect on premiums, but no final action on House Bill 413 was taken in the portion of the meeting provided.
MO

Missouri 2026 Regular Session

Joint Committee on Administrative Rules Jun 12th, 2026 at 10:00 am

Joint Committee on Administrative Rules

Transcript Highlights:
  • On the pharmacy side, it could be a pharmacy intern or a pharmacy technician.
  • On the pharmacy side, it could be a pharmacy intern or a pharmacy technician.
  • Y is the family practitioner, same basic practice.
  • nurses, registered nurses, medical interns, medical residents, pharmacy interns, and pharmacy technicians
  • This is the pharmacy where it was picked up.
Keywords: 959, house, all
HI
Transcript Highlights:
  • That is like judging the entire pharmacy sector by a handful of fraud cases.
  • That is like judging the entire pharmacy sector by a handful of fraud cases.
  • That is like judging the entire pharmacy sector by a handful of fraud cases.
  • That is like judging the entire pharmacy sector by a handful of fraud cases.
  • reveal any medical billing practices reveal any medical billing practices from<00:29:36.840>
DE
Transcript Highlights:
  • to a pharmacy, I don’t like it.
  • practice agreement.
  • So we go into a pharmacy today...
  • Because people walk into the pharmacy right now.
  • that is sold right there at the pharmacy itself.
Summary: The House convened with Girl State participants presiding for part of the session, including introductions of the student leadership and a unanimous voice vote passing House Concurrent Resolution 152 honoring the young women participating in Delaware Girl State. The chamber also welcomed congressional interns and other guests, accepted the prior day’s minutes, and observed a moment of silence for Nathan Cynix and Kara Feeley before prayer and the Pledge of Allegiance. A major portion of the meeting was devoted to tributes for Representative Ron Gray, who was recognized for his 14 years of service and his work on issues such as bond bills, dredging, bike paths, small business, constituent service, and agriculture-related funding. Multiple members from both parties praised his humor, honesty, mentorship, and dedication to the House and his district. Gray responded with extended remarks reflecting on his family legacy, legislative service, and appreciation for colleagues and staff, and the chamber later sang “Take Me Out to the Ball Game” at his request. The House then received communications, including Senate messages returning several bills and informing the chamber of Senate passage of additional measures. Members were also told that the FY27 bond bill, House Bill 500, had been placed on desks as a gift for review. The House read in Consent Agenda S, which included House Bill 476, House Joint Resolution 13, Senate Substitute 1 for Senate Bill 168, Senate Bill 297, Senate Substitute 1 for Senate Bill 319, and Senate Joint Resolution 21, and began a roll call vote on the consent agenda.
MO

Missouri 2026 Regular Session

Joint Committee on Administrative Rules Jun 12th, 2026

Joint Committee on Administrative Rules

Transcript Highlights:
  • On the pharmacy side, it could be a pharmacy intern or a pharmacy technician.
  • On the pharmacy side, it could be a pharmacy intern or a pharmacy technician.
  • And this becomes very practical because each patient is unique.
  • medical residents, pharmacy interns, and pharmacy technicians, period.
  • the nature of the practice quite a bit.
Summary: The Joint Committee on Administrative Rules met to consider a Missouri Prescription Drug Monitoring Program rule proposal after the Department of Natural Resources withdrew its items. The hearing focused on 1 CSR 60-1.010, which would expand delegate-level PDMP access to additional licensed behavioral health professionals, including licensed clinical social workers, licensed master social workers, marital and family therapists, professional counselors, and psychologists, while also correcting prior rule language involving medical assistants and clinical nurse specialists. Testimony from the PDMP executive director and supporters from Compass Health and the Department of Mental Health argued the change would improve care coordination, medication reconciliation, and safety in multidisciplinary behavioral health settings, especially CCBHCs. They said access would remain limited to licensed professionals working under a prescriber/dispenser relationship, with individual logins and penalties for misuse. Opponents and some committee members raised concerns that the rule would expand access beyond the original statutory framework without legislative change, could be used beyond treatment purposes, and should instead be addressed through statute rather than rulemaking. After public testimony, the committee debated whether the proposal exceeded statutory authority and whether the expansion was too substantive for rulemaking alone. A motion was made to disapprove the rule on grounds including lack of statutory authority, conflict with state law, and arbitrariness. The motion passed by a roll call vote of 7-1, and the committee disapproved Rule 1 CSR 60-1.010 before adjourning.
WY

Wyoming 2026 Regular Session

Joint Labor, Health & Social Services Committee, May 15, 2026 - AM

Labor, Health & Social Services

Transcript Highlights:
  • in Wyoming pharmacies right now, community pharmacies specifically.
  • So there, instead of going to a community pharmacy to practice where you can help the immediate people
  • you community pharmacy to practice where you community pharmacy to practice where you can<02:31:24.280
  • where we're taught to practice. where we're taught to practice.
  • . pharmacy. pharmacy.
Keywords: 916, all
NH

New Hampshire 2025 Regular Session

House Health, Human Services and Elderly Affairs (04/23/2025)

Health, Human Services & Elderly Affairs

Transcript Highlights:
  • <01:52:23.679> practice<01:52:24.080> act, 318, which is the pharmacy practice act,
  • 318, which is the pharmacy practice act, and<01:52:24.719> we<01:52:24.880> also<01:52
  • Representative Weber then asked whether there are limits in the actual pharmacy practice act that would
  • respect in the underlying pharmacy respect in the underlying pharmacy practice<02:03:31.440>
  • To practice, pharmacists must graduate from a Doctor of Pharmacy program accredited by the Accreditation
Keywords: 1189, house, all
MA

Massachusetts 2025-2026 Regular Session

Joint Committee on Financial Services Jun 21st, 2026 at 11:00 am

Joint Committee on Financial Services

Transcript Highlights:
  • One is we bring cases and investigate unfair trade practices.
  • One is we bring cases and investigate unfair trade practices.
  • 900 of the 1,100 are chain pharmacies.
  • 900 of the 1,100 are chain pharmacies.
  • We have been practicing as a profession for over 150 years.
Keywords: 995, all
Summary: The committee held an informational opening hearing for the Financial Services Committee, with Chair Murphy and Senator Feeney introducing new and returning members and explaining that no bills were being heard that day beyond brief introductory testimony. Commissioner of Banks Mary Gallagher thanked the committee for last session’s money transmission modernization law, and several members echoed appreciation for her office’s work. The hearing then featured a long series of stakeholder introductions and overviews of their priorities for the session. Testimony covered a wide range of financial, insurance, housing, health care, and consumer issues. Banking and mortgage groups discussed housing affordability, foreclosure delinquencies, flood insurance, regulatory changes, and the impact of federal policy shifts. Insurance representatives raised concerns about auto and homeowners market pressures, labor rates, tariffs, rebates, e-titling, third-party litigation funding, and public adjuster restrictions. Consumer and advocacy groups highlighted debt collection reform, earned wage access, retirement savings access, public banking, and consumer protections in financial services. Several speakers also emphasized the need for committee expertise and offered themselves as resources for future bills. Health-related organizations focused on insurance mandates, prior authorization, behavioral health access, pharmacy benefit manager reform, community health center funding, maternal health and midwifery reimbursement, and anesthesia reimbursement parity. Other groups, including credit unions, retailers, auto dealers, dental and medical associations, and behavioral health providers, described their roles in the Commonwealth and previewed legislation or policy areas they expect to follow this session. No votes were taken; the meeting was informational and ended after testimony from the sign-up list and a few late additions.
LA

Louisiana 2026 Regular Session

Senate May 29th, 2026

Louisiana Senate Floor Meeting

Transcript Highlights:
  • career to Ryan LLC, where she most recently served as a principal in the company's U.S. advocacy practice
  • career to Ryan LLC, where she most recently served as a principal in the company's U.S. advocacy practice
  • Transportation and Development to conduct a review of its public-private partnership contracting practices
LA

Louisiana 2026 Regular Session

Senate May 29th, 2026

Louisiana Senate Floor Meeting

Transcript Highlights:
  • career to Ryan LLC, where she most recently served as a principal in the company's U.S. advocacy practice
  • career to Ryan LLC, where she most recently served as a principal in the company's U.S. advocacy practice
Summary: The Senate convened with a quorum, received a prayer and pledge, adopted the journal, and heard messages from the House reporting final passage of several Senate bills and concurrence in SCR 86 and 87. The chamber also observed personal privileges honoring the lives of Edith K. Kirkpatrick and Susan Ann Traylor Bidick, with family members present and a moment of silence held for Bidick. The House later refused concurrence on Senate amendments to HB 42 and HB 159. The Senate then took up a series of resolutions, most of which were adopted without objection. These included studies on energy infrastructure and modernization (SR 174, amended to add an alternative energy industry representative and a consumer advocate), breast pump Medicaid reimbursement (SR 175), digital student IDs (SR 176), lethality assessment protocols in domestic violence cases (SR 177), problem gambling prevention (SR 178), community water system grading (SR 179), condolences for Sharon Courtney (SR 180), and expansion of the Louisiana Tumor Registry (SR 181). The chamber also adopted SCR 85 honoring the Sam Houston High School Broncos baseball team after a recorded vote of 36 yeas and 8 nays. On bills returned from the House, HB 1222 on grocery initiative grants failed on final passage by a vote of 18 yeas and 19 nays. SB 312 had House amendments rejected, SB 348 and SB 485 had House amendments concurred in, and SB 121 on congressional redistricting was the subject of extensive debate over racial gerrymandering, district configuration, and expected litigation before the Senate concurred in the House amendments by 28 yeas and 10 nays. The Senate also concurred in several House concurrent resolutions, including studies or reports on flooded corn and migratory waterfowl, deer hunting with dogs in Kisatchie National Forest, support for a Senator Kennedy letter to the Fish and Wildlife Service, boating safety reporting, and subsurface data review. Finally, HB 944 creating a Women’s Health Consortium within the Department of Health was amended to address funding concerns and convert it into a more task-force-like structure, then passed 37-0 with nine coauthors. The Senate then recessed until 1:30 p.m. to continue work, including conference committee reports.
MN
Transcript Highlights:
  • challenges of running a small practice challenges of running a small practice are<00:05:13.039><
  • costs that are not a contract pharmacy costs that are not a contract pharmacy so<00:57:49.839>
  • , more than one contract pharmacy.
  • more than one contract pharmacy. more than one contract pharmacy.
  • from the pharmacy.
Keywords: 919, house, all
Summary: The committee first approved the March 11, 2026 minutes, then heard House File 4048, which would exempt chiropractors from Minnesota’s provider tax if they are no longer eligible to provide chiropractic benefits under Medicaid/MinnesotaCare. Representative Robbins said the bill corrects an unfair situation because chiropractors still pay the tax even though the benefit was eliminated. Testifiers from the Minnesota Chiropractic Association and a longtime chiropractor supported the bill, arguing that most chiropractors are small-business owners and should not pay a tax for services they can no longer provide. Several members said they supported restoring chiropractic coverage instead of changing the tax, and there was discussion about whether the tax applies to all providers and whether it is effectively passed on to patients. The committee adopted a motion to recommend HF 4048 to the Committee on Taxes. The committee then took up House File 3893, as amended, a bill to restrict artificial intelligence from engaging in psychotherapy or counseling with humans. The author and supporters said the bill is intended to prevent AI chatbots from posing as therapists or counseling vulnerable people, citing reports of suicides and other harms linked to chatbot interactions. The A2 amendment was adopted; the author said it reflected stakeholder concerns and added informed-consent language. Testifiers in support, including a psychologist and a suicide-prevention nonprofit leader, urged strong safeguards and said AI should not replace licensed professionals in crisis settings. Other testimony raised concerns about overbreadth and unintended effects. TechNet and a rural mental health provider said the bill should be narrowed so it applies to clinical therapy rather than wellness or educational tools, and should allow supervised AI uses such as transcription and administrative support. Members discussed rural access, existing licensing-board authority, privacy laws, and whether the bill should target AI companies directly rather than licensed clinicians. The transcript ends during continued discussion of HF 3893, with no final committee action shown in the excerpt.
DE
Transcript Highlights:
  • There are pharmacies. multiple directions and there are pharmacists. There are pharmacies.
  • But here's the practical.
  • practice agreement.
  • practice agreement.
  • This bill is going to, or this practice is going to be, widely used in regular retail pharmacies such
Keywords: 1064, all
NH
Transcript Highlights:
  • . pharmacy. pharmacy.
  • from the wholesaler to the pharmacy. from the wholesaler to the pharmacy. Okay?
  • each pharmacy. Correct. That's correct. each pharmacy. Correct. That's correct.
  • or to a mail order pharmacy.
  • of independent pharmacies.
Keywords: 928, house, all
Summary: The committee first heard Senate Bill 47, sponsored by Sen. Regina Birdsell at the request of the Insurance Department. The bill would codify the department’s interpretation that a birth mother’s health insurance is the primary coverage for a newborn, unless the mother has no insurance or coverage under an employer-sponsored plan. Birdsell and Insurance Commissioner DJ Benton Court said the measure is a clarification of existing practice and intended to protect vulnerable newborns; a question from Rep. Miles clarified that if a young woman is on her parents’ policy, the newborn would generally be covered under that family coverage. The hearing on SB 47 was then closed. The committee then took up Senate Bill 121, introduced by Grant Bosi for Sen. Kevin Avard, which would require insurers to notify the Insurance Department when they stop writing an entire line of business or, in some cases, Medicare Advantage plans. Commissioner Benton Court said the bill arose from disruption in the Medicare Advantage market, where consumers, brokers, and the department were confused by carriers changing or ending offerings; he said the department wanted a simple notification requirement so it could better advise consumers. Members discussed network adequacy, county-based service areas, and the fact that the bill would make notice a condition of licensure, with possible fines or license action for noncompliance. Witness Paula Rogers of AHIP said her group supported the bill if amended, and the department indicated it would support a change from a 120-day notice period to 90 days to align with state rules; the committee planned to work on an amendment in subcommittee. Finally, the committee heard Senate Bill 247, introduced by Rep. Brian Cole, which would prohibit network exclusion of pharmacies that refuse to dispense prescriptions when PBM reimbursement is below acquisition cost. Cole argued the bill is meant to stop pharmacies from being forced to sell drugs at a loss, describing PBMs as middlemen and saying the measure is a compromise that protects local pharmacies. Members questioned whether consumers would pay more and whether pharmacies voluntarily enter PBM contracts; Cole responded that the bill would let pharmacies refuse unprofitable fills while consumers could still obtain the drug through mail order or other channels. He also said the issue has changed over time because the practice now affects a much larger share of generics and is concentrated among a few PBMs. The hearing remained open as questions continued, with no vote taken in the excerpt.
LA

Louisiana 2026 Regular Session

Health and Welfare May 6th, 2026

Health and Welfare

Transcript Highlights:
  • What I'm suggesting is that a licensed practical nurse, who is licensed...
  • How is Louisiana's current law functioning in practice, inside hospitals, emergency rooms, pharmacies
  • In practice, inside hospitals, emergency rooms, pharmacies, and urgent care settings.
  • I'd like to point out a few practical considerations.
  • The Board of Pharmacy has not presented this as an issue.
MN
Transcript Highlights:
  • Pharmacies must comply with contract.
  • It is every prescription that we fill in our retail pharmacy.
  • care, clinic services, and pharmacy care, clinic services, and pharmacy access<00:25:05.039>
  • processes of could the board of pharmacy processes of could the board of pharmacy look<00:29:31.840
  • <00:32:06.960> is which means more than one pharmacy is which means more than one pharmacy
Keywords: 919, house, all
Summary: House File 369 was the main topic, with House authors Rep. Natalie Zeleznikar, Rep. Robert Bierman, and Rep. Dave Baker arguing that the bill would give Minnesota’s 2024 340B law “teeth” by enforcing protections for nonprofit and rural hospitals’ access to the federal drug pricing program. They said the measure costs the state nothing, aligns with similar laws in more than 20 other states, and is needed before adjournment to help hospitals close funding gaps, support services like emergency care, obstetrics, behavioral health, and pharmacy access, and preserve care in remote communities. Several hospital leaders from across greater Minnesota testified that 340B revenue helps keep their facilities viable and that losing it would threaten services and, in some cases, hospital survival. Witnesses described severe financial pressure on rural hospitals, including reimbursement cuts, workforce shortages, inflation, and rising drug costs. Leaders from United Hospital District in Blue Earth, Lakewood Health System in Staples, Ely-Bloomenson Community Hospital, Northshore Health in Grand Marais, Community Memorial Hospital in Cloquet, and Cuyuna Regional Medical Center in Crosby said their hospitals serve as safety-net providers and often operate with thin or negative margins. They emphasized long travel times to other hospitals, seasonal tourism pressures in some areas, and the importance of local emergency, ambulance, inpatient, and specialty services. The Minnesota Hospital Association president also criticized pharmaceutical company messaging and said nonprofit hospitals are working around the clock to maintain access. In response to questions, Zeleznikar said she had considered other enforcement approaches but now supported using the original Senate-passed bill, citing concerns about fraud and the difficulty of alternative enforcement mechanisms. She and hospital leaders distinguished this bill from a separate hospital stabilization-grant proposal, saying both are needed but serve different purposes. No vote was taken at the meeting, and the speakers repeatedly urged House leadership to bring the bill to the floor before session ends.
MO

Missouri 2026 Regular Session

Substance Abuse Prevention and Treatment Task Force Jun 24th, 2026

Substance Abuse Prevention and Treatment Task Force

Transcript Highlights:
  • And this enables folks to get it at any pharmacy.
  • The next best practice is public health.
  • And then my fifth best practice model is methadone.
  • My primary care practice... Thank you for asking that.
  • But we were turned down by the Board of Pharmacy, who said that we couldn't license any mobile pharmacies
Summary: The task force meeting opened with new leadership announcements, including Senator Nick Schroer thanking outgoing chair Representative John Black and naming Representative Del Taylor as vice chair. After some initial technical difficulties with audio and Zoom, members reviewed the task force’s statutory charge under Missouri law: to hold hearings on substance use, explore solutions, draft or modify legislation, and produce recommendations for prevention and treatment. The chair said the goal for this year is to develop concrete legislative ideas for the next session, with hearings focused first on field experts and later on alternative therapies and the Department of Mental Health. Dr. Rachel Winograd gave the first major presentation, describing Missouri’s overdose crisis as increasingly complex and driven primarily by fentanyl, now compounded by xylazine and metatomidine. She said overdose deaths have declined for a third straight year, with preliminary 2025 data around 1,200 deaths, and attributed the decline to a smaller fentanyl supply, wider naloxone availability, and fewer young people entering use. Her main recommendations were to focus on reducing harm rather than trying to eliminate drug use, expand evidence-based medications for opioid use disorder—especially methadone and buprenorphine—improve access to naloxone, and loosen methadone regulations, including take-home doses, the federal 72-hour rule, and broader methadone units. She also emphasized that peer support, housing, transportation, and other practical supports matter, and noted that naloxone can still reverse fentanyl overdoses even when tranquilizers are present. Dr. Heidi Miller, the state medical director, followed with two recommendations: integrate substance use disorder care into whole-person health care and follow the science when considering substance-related legislation. She argued that primary care, maternal health, workforce training, EMS, public health, and methadone access should all be part of a coordinated model, and said reimbursement should support teams rather than isolated providers. She also urged stronger enforcement of parity between behavioral health/SUD and physical health coverage, and highlighted tobacco and alcohol as major, under-addressed causes of death in Missouri. Dr. Doug Burgess then reinforced the need for a coordinated continuum of care, comparing substance use treatment to the seamless system used for heart attacks, and said patients should have standardized assessment, discharge planning from day one, transition coordinators, peer recovery coaches, and better information-sharing between levels of care. Members asked questions about relapse, treatment court, EMS referral barriers, reimbursement, and whether buprenorphine can be started in the field; no votes were taken, and the meeting ended with plans to continue hearing testimony and use it to shape future policy recommendations.
AL

Alabama 2025 Regular Session

Alabama House Feb 20th, 2025

Alabama House Floor Meeting

Transcript Highlights:
  • Remember next Wednesday, softball practice.
  • It codifies the practice of approving... codifies the practice of approving and authorizing agreements
  • impacts my practice.
  • This involves the Board of Pharmacy.
  • ... oversaw the pharmacy industry, and I do have a substitute.
Keywords: 1136, house, all
TX

Texas 89th Regular

Public Health Aug 22nd, 2025

Public Health

Transcript Highlights:
  • So once they are in the pharmacy, that’s going to be the Board of Pharmacy.
  • It's regulated by the Medical Practice Act and it's regulated by the Texas Pharmacy Act.
  • In the Pharmacy Act, in 0.056, it says specifically that a pharmacy.
  • It's the pharmacy, Board of Pharmacy.
  • If a minor goes up to the pharmacy...
Bills: HB 265, HB25
AL

Alabama 2026 1st Special Session

Alabama Senate Fiscal Responsibility and Economic Development Committee Jan 21st, 2026

Fiscal Responsibility and Economic Development

Transcript Highlights:
  • start practicing. start practicing.
  • They can work, they can practice, >> right?
  • practice that we do in the classroom. practice that we do in the classroom.
  • I was trying to find the verbiage here. uh in the pharmacy board where in uh in the pharmacy board where
  • year on the pharmacy board. year on the pharmacy board. um<00:11:29.279> the<00:11:29.760
Bills: HB59, SB15, SB96, SB104, SB137